IL Therapeutics
IL Therapeutics Inc. was previously owned by Western Life Sciences Venture Fund LP
and in 2006 its shares were purchased by Pacgen Biopharmaceuticals Corporation.History
operates a bioprocessing laboratory which facilitated biomedical research. IL Therapeutics was developed from research first begun at the Western College of Veterinary Medicine.Pharmaceuticals
Currently IL Therapeutics is working on a drug candidate, IL-8K11R/G31P for relief of Acute Respiratory Distress Syndrome. The Saskatchewan Research council, SRC also assisted with the funding of this project through the Agriculture Development Fund - SRC Industry Venture Fund. With the successful progression of G31P, the University of Saskatchewan Industry Liaison Office decided to commercialize a commercialize this new drug treatment. This research has been sponsored by a $3 million boost from the Western Life Sciences Venture Fund
